BackUltragenyx Pharmaceutical Overview
Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Target Price

Analysts' 12-month price predictions for RARE.

Share Price

$36.61

Average Target Price

$89.50144.5% upside

2 analysts in the last 4 months

High: $115 | Low: $64

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2025-03-17Piper Sandler$115214.1% upsideOpen
2025-03-07Morgan Stanley$6474.8% upsideOpen
2024-11-06H.C. WainwrightEd Arce$95159.5% upsideOpen
2024-11-06Leerink PartnersJoseph Schwartz$85132.2% upsideOpen
2024-06-06Goldman SachsSalveen Richter$6783% upsideOpen
2024-05-31Stifel NicolausDae Gon Ha$127246.9% upsideOpen
2024-05-31Raymond JamesChristopher Raymond$135268.8% upsideOpen
2024-05-31Robert W. BairdJoel Beatty$7296.7% upsideOpen
2024-05-31Canaccord GenuityWhitney Ijem$111203.2% upsideOpen
2024-04-15Stifel NicolausDae Gon Ha$124238.7% upsideOpen
2024-04-15Raymond JamesChristopher Raymond$130255.1% upsideOpen
2023-02-03Morgan Stanley$95159.5% upsideOpen
2022-12-30H.C. Wainwright$82124% upsideOpen
2022-07-28Piper SandlerChristopher Raymond$130255.1% upsideOpen
2022-07-01Stifel Nicolaus$142287.9% upsideOpen
2022-05-24Goldman Sachs$101175.9% upsideOpen
2022-05-18Piper SandlerChristopher Raymond$135268.8% upsideOpen
2022-05-06Morgan Stanley$109197.7% upsideOpen
2022-05-06Leerink Partners$115214.1% upsideOpen
2022-01-10Cowen & Co.Yaron Werber$124238.7% upsideOpen
2021-11-03CitigroupYigal Nochomovitz$150309.7% upsideOpen
2021-11-03WedbushLaura Chico$92151.3% upsideOpen
2021-09-27Piper SandlerChristopher Raymond$170364.4% upsideOpen
2021-08-19UBSEsther Rajavelu$7399.4% upsideOpen
2021-08-03BarclaysGena Wang$141285.1% upsideOpen